Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Helix BioPharma Enterprise Value: 30.41M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 30.41M |
May 15, 2024 | 30.41M |
May 14, 2024 | 30.41M |
May 13, 2024 | 30.41M |
May 10, 2024 | 30.41M |
May 09, 2024 | 30.41M |
May 08, 2024 | 30.41M |
May 07, 2024 | 30.41M |
May 06, 2024 | 30.41M |
May 03, 2024 | 30.41M |
May 02, 2024 | 30.41M |
May 01, 2024 | 30.41M |
April 30, 2024 | 30.41M |
April 29, 2024 | 30.41M |
April 26, 2024 | 30.41M |
April 25, 2024 | 30.41M |
April 24, 2024 | 30.41M |
April 23, 2024 | 30.41M |
April 22, 2024 | 30.41M |
April 19, 2024 | 30.41M |
April 18, 2024 | 30.41M |
April 17, 2024 | 30.41M |
April 16, 2024 | 30.41M |
April 15, 2024 | 30.41M |
April 12, 2024 | 30.41M |
Date | Value |
---|---|
April 11, 2024 | 30.41M |
April 10, 2024 | 30.41M |
April 09, 2024 | 30.41M |
April 08, 2024 | 30.41M |
April 05, 2024 | 28.65M |
April 04, 2024 | 28.65M |
April 03, 2024 | 28.65M |
April 02, 2024 | 28.65M |
April 01, 2024 | 28.65M |
March 28, 2024 | 28.65M |
March 27, 2024 | 28.65M |
March 26, 2024 | 28.65M |
March 25, 2024 | 30.88M |
March 22, 2024 | 30.88M |
March 21, 2024 | 30.88M |
March 20, 2024 | 30.88M |
March 19, 2024 | 30.88M |
March 18, 2024 | 29.43M |
March 15, 2024 | 29.43M |
March 14, 2024 | 29.43M |
March 13, 2024 | 29.43M |
March 12, 2024 | 29.43M |
March 11, 2024 | 29.43M |
March 08, 2024 | 29.43M |
March 07, 2024 | 29.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
24.35M
Minimum
Jul 11 2019
151.77M
Maximum
Apr 17 2020
57.00M
Average
35.59M
Median
Dec 14 2020
Enterprise Value Benchmarks
Acasti Pharma Inc | 0.8274M |
Aurinia Pharmaceuticals Inc | 474.73M |
Edesa Biotech Inc | 11.74M |
Lexaria Bioscience Corp | 35.30M |
Xenon Pharmaceuticals Inc | 2.345B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.9232M |
Total Expenses (Quarterly) | 0.9217M |
EPS Diluted (Quarterly) | -0.0074 |
Earnings Yield | -19.75% |